Skip to main content

Multicohort analysis unveils axon guidance pathways linking small for gestational age to spirometric restriction.

Nature communications2026-05-03PubMed
Total: 87.0Innovation: 9Impact: 0Rigor: 0Citation: 0

Summary

Across multiple birth cohorts, about one-third of SGA newborns showed a cord-blood endotype characterized by dysregulated axon-guidance proteins. These signals inversely tracked with later spirometric restriction, and convergent support from GWAS and a sheep model linked axon-guidance genes to spirometric indices.

Key Findings

  • Approximately one-third of SGA children exhibit a cord-blood molecular endotype featuring dysregulated axon-guidance proteins.
  • Later-life peripheral blood levels of these proteins inversely associate with spirometric restriction.
  • GWAS and an experimental sheep model provide convergent evidence linking axon-guidance genes to spirometric indices.

Clinical Implications

Identifying an axon-guidance molecular endotype in SGA infants could enable early risk stratification and surveillance for restrictive ventilatory impairment, informing preventive strategies.

Why It Matters

This study proposes a mechanistic link between neurodevelopmental pathways and pulmonary development, redefining how early-life growth restriction imprints long-term lung function.

Limitations

  • Causality remains inferential despite genetic and animal-model triangulation.
  • Generalizability beyond the included cohorts and populations requires validation.

Future Directions

Prospective validation of the axon-guidance endotype in diverse populations and interventional studies to test modifiable pathways influencing lung growth.

Study Information

Study Type
Cohort
Research Domain
Pathophysiology
Evidence Level
II - Prospective/observational cohort analyses with supportive experimental validation
Study Design
OTHER